Recent advances in our understanding of neurodegeneration
The DOI matches its Crossref record; 617 of the 618 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are featured by progressive dysfunction and death of cells in selected areas in the nervous system, determining clinical presentation. Neuronal loss is associated with conformational changes in proteins that result in extra- and intra-cellular accumulation of misfolded proteins, representing the hallmarks of many neurodegenerative disorders, summarized as proteinopathies. Intermediate forms such as oligomers and protofibrils are thought to have cytotoxic effects to neurons. Major basic processes, caused by genetic, environmental, and endogenous factors, in addition to abnormal protein dynamics with defective degradation due to deficiency of the ubiquitin-proteosomal-autophagy system, include oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunction, disruption of neuronal Golgi apparatus and transport, molecular chaperones, neurotrophins and "neuroinflammatory" processes. These mechanisms are interrelated in vicious circles finally leading to programmed cell death. A common feature of these conditions is a long run until sufficient protein accumulates, followed by a cascade of symptoms over many years with increasing disability leading to death. This provides a wide therapeutic window, especially in groups at risk identified early and preclinical diagnosis becomes feasible. Neurodegenerative disorders are classified according to known genetic mechanisms or to the major components of protein deposits. Although this has been a productive paradigm for the development of diagnostic consensus criteria, recent molecular biologic and genetic approaches have revealed that there are both overlap and intraindividual diversities between different phenotypes, related to synergistic mechanisms between major pathologic proteins (beta-amyloid, tau, alpha-synuclein, TDP-43), suggesting common pathogenic mechanisms. The nature, time course, and molecular causes of cell degeneration and demise, and the role of various pathogenic factors are a matter of considerable debate, but recent studies have provided insight into the basic processes in neurodegeneration and the roles of cell death programs common to this complex group of disorders, offering new ways for future prevention and treatment strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles are common age-related lesions that are presumed to play primary pathophysiological roles in the dementia of Alzheimer’s disease (AD)(Jellinger, 2009).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Jellinger, 2009
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992 · cited 1×
“This extracellular fragment of APP, and death receptor G (DRG) activating a widespread caspase-dependent self-destructing process (via caspase-6), might be a major culprit behind AD (Nikolaev et al. 2009; Osherovich 2009).”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · cited 1×
“Apoptosis can occur locally, without damaging healthy adjacent cells (Elmore 2007).”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 2×
“…mechanism involved in the three autophagic pathways: chaperone mediated autophagy (CMA), micro- and macroautophagy, and their relevance in ND have been reviewed recently (Boland et al. 2008; Cherra and Chu 2008; Deretic 2008; Levine and Kroemer 2008; Shacka et al. 2008; Todde et al. 2009).”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 18×
“The precise sequence of events in FRDA pathogenesis is uncertain.”
BackgroundResultInfluentialSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 2×
“…and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan…”
BackgroundMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 4×
“…of radicals and peroxynitrite attack have been detected in postmortem AD brain, which, at least in part, are produced by activated microglia, and, together with anomalous release of cytokines, may be a progression factor in AD (Block et al. 2007; Maccioni et al. 2009; Weisman et al. 2006).”
BackgroundInfluentialCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 2×
“The ‘‘toxic oligomer’’ hypothesis is supported by the finding that a single-domain antibody can recognize a common conformational epitope that is displayed by several disease-associated proteins, including b-amyloid (Ab), a-synuclein (aSyn), tau protein, prions, and polyglutamine (polyQ) containing peptides (Hernandez…”
BackgroundParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · cited 2×
“Parkin plays a role in maintaining mitochondrial homeostasis, improves mitochondrial dysfunction, regulates their remodeling, promotes their autophagy, promotes DNA repair, and protects against genotoxicity (Kao 2009; Mitsui et al. 2008; Narendra et al. 2008; Park et al. 2009; Poole et al. 2008; Van Laar and Berman 20…”
BackgroundNeurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 2×
“Free radical oxygen chemistry plays an important pathogenic role in all these conditions, though it is as yet undetermined what types of oxidative damage occur early in the pathogenic cascade and which ones are secondary manifestation of dying neurons (Emerit et al. 2004; Mancuso et al. 2006; Sayre et al. 2008).”
BackgroundMechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184 · cited 2×
“, by oxidative injury— proteins that have the potential to induce cellular damage (Pickart 2001; Voss and Grune 2007).”
BackgroundTDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630 · cited 1×
“More recently, mutations of the RNA-metabolizing protein TDP43 have been uncovered in rare autosomal-dominant familial cases (Sreedharan et al. 2008) and TDP-43 deposits are seen in most sALS cases.”
BackgroundOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · cited 5×
“many diseases including NDDs and their models (see Calabrese et al. 2007; Fatokun et al. 2008; Gardiner et al. 2009; Halliwell 2006; Nunomura et al. 2009; Petrozzi et al. 2007).”
BackgroundInfluentialMutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · cited 1×
“Increasing evidence supports the notion that abnormal protein–protein interactions and/or the lesions that result from them trigger vicious circles leading to dysfunction and death of neuronal and glial cells with ensuing disintegration of neuronal networks (Palop et al. 2006; Seeley et al. 2009).”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · cited 2×
“2009) and recent evidence that NFTs in experimental models do not directly correlate with neuron loss (Andorfer et al. 2005; SantaCruz et al. 2005) suggests that affected neurons may be able to withhold NFT formation for a long time before they degenerate.”
BackgroundMitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985 · cited 2×
“They provide energy from aerobic metabolism; oxidative phosphorylation via the oxidative phosphorylation system (OXPHOS) is the principal source of high-energy compounds (McBride et al. 2006; Yang et al. 2008b).”
BackgroundNeuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · cited 2×
“…and proliferation of MHC class II positive microglia releasing pro-inflammatory cytokines, NO, complements, other substances mediating inflammatory reactions, and OS that may be both inducing factors or sequelae of neuronal death (Hald et al. 2007; Hirsch and Hunot 2009; Schwab and McGeer 2008).”
BackgroundOxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“Oxidative damage to nuclear and mtDNA occurs in the earliest detectable phase of AD, PD and HD (Browne and Beal 2006; Nunomura et al. 2001, 2009; Wang et al. 2006), but also in normal aging (Pratico and Sung 2004).”
BackgroundOxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · cited 2×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundIron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · cited 2×
“…2005) and Friedreich ataxia (FRDA) are associated with mutations in genes that encode proteins involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by AD and PD (Altamura and Muckenthaler 2009; Gerlach et al. 2006; Linert et al. 2006; Zecca et al. 2004).”
BackgroundAutophagy in cell death: an innocent convict?
Levine, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26390 · Cited by 1,676 · cited 1×
“Thus, in NDDs, there may occur forms of cell death that are neither classical necrosis nor apoptosis with occasional autophagic degeneration (Levine and Yuan 2005).”
BackgroundThe roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625 · cited 4×
“2009), while the process, known as microautophagy, is poorly understood (Rubinsztein 2006).”
BackgroundInfluentialBender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · cited 2×
“High levels of mtDNA deletions in SN neurons in aging and PD suggest that they are important in the selective neuronal loss in these conditions (Bender et al. 2006), as are decreases in ATP production and ATPsensitive potassium channels (Liss et al.”
BackgroundCellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560 · cited 1×
“Prion protein (PrP) is one of the main cellular receptors for oligomeric Ab (Lauren et al. 2009).”
BackgroundMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · cited 1×
“Activated microglia may be both neurotoxic and neuroprotective, depending on several factors including aging, but the causes for transformation between the two actions remains largely unknown (Block and Hong 2005; Sawada et al. 2008).”
BackgroundAutophagic cell death: the story of a misnomer
Kroemer, G., & Levine, B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2529 · Cited by 1,453 · cited 2×
“rather than by autophagy (Kroemer and Levine 2008; Levine and Kroemer 2008), a normal physiological process active in both homeostasis and atrophy, probably representing a failure of neuroprotective mechanisms, is characterized by the formation of numerous autophagic vacuoles, endocytosis, enlargement of the GA as a s…”
BackgroundHolmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · cited 5×
“The problems of AD and tg animal models treated by immunotherapy causing plaque removal and increase in severity of cerebral amyloid angiopathy (CAA) (Boche et al. 2008; Boche and Nicoll 2008; Holmes et al. 2008; Prada et al. 2007; Wilcock et al. 2004; Wisniewski and Konietzko 2008) are not discussed here (see Foster…”
BackgroundInfluentialα-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F., et al. (2006) · Science · doi:10.1126/science.1129462 · Cited by 1,376 · cited 1×
“…fragmentation is an early and probably irreversible lesion in ND, e.g., in nigral neurons with aSyn-positive inclusions in PD (Fujita et al. 2006), caused by a variety of mechanisms including accumulation of misfolded proteins. aSyn has been shown to block ER Golgi traffic (Cooper et al. 2006).”
BackgroundABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280 · cited 1×
“High levels of mtDNA deletions in SN neurons in aging and PD suggest that they are important in the selective neuronal loss in these conditions (Bender et al. 2006), as are decreases in ATP production and ATPsensitive potassium channels (Liss et al. 2005; Moore et al. 2005).”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 2×
“Parkin deficiency increases vulnerability to inflammation-related nigral degeneration (Frank-Cannon et al. 2008), while human neuromelanin induces neuroinflammation and degeneration in the rat SN (Zecca et al. 2008) and aggregated aSyn activates microglia (Zhang et al. 2005b).”
BackgroundPropagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252 · cited 1×
“The intracellular fibrils can seed fibril formation of recombinant tau monomers in vitro, indicating propagation of protein misfolding from the outside to the inside of cells (Frost et al. 2009).”
BackgroundProteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
Mukhopadhyay, D., & Riezman, H. (2007) · Science · doi:10.1126/science.1127085 · Cited by 1,221 · cited 2×
“However, ubiquitination of protein substrates without proteolysis and proteasome-independent function of Ub in endocytosis and signaling (Mukhopadhyay and Riezman 2007), and Ubindependent degradation of proteins by the proteasome (Jariel-Encontre et al. 2008) have been described, unveiling…”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 3×
“Axonal transport in Alzheimer disease and tauopathies Axonal transport is impaired in AD and other tauopathies (Roy et al. 2005; Schindowski et al. 2008a), probably early in their pathogenesis (Stokin et al. 2005).”
BackgroundMitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203 · cited 2×
“abnormalities and less resistance to OS induced by paraquat (Greene et al. 2003).”
BackgroundThe axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,185
Friedberg, E. C. (2003) · Nature · doi:10.1038/nature01408 · Cited by 1,177
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · cited 2×
“T cells and requires the expression of Fas/FasL but not the IFNc cytotoxic pathway (Brochard et al. 2009).”
BackgroundOlichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P., & Lenaers, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200677200 · Cited by 1,168
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149 · cited 1×
“Small molecules can enhance proteostasis by binding to and stabilizing specific proteins (chaperones) or by increasing the proteostasis network capacity (proteostasis regulators) (Powers et al. 2009).”
BackgroundXu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., Rush, J., Hochstrasser, M., Finley, D., & Peng, J. (2009) · Cell · doi:10.1016/j.cell.2009.01.041 · Cited by 1,136 · cited 2×
“Unconventional poly-Ub chains are critical for UPS function (Xu et al. 2009), and Ub plays an important role in the clearance of nonfunctional RNAs (Fujii et al.”
BackgroundKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127 · cited 1×
“On the other hand, dopamine (DA) tends to stabilize the oligomeric forms and prevents aggregation of aSyn, which may be one of the reasons for the selective vulnerability of DAergic neurons (Conway et al. 2001).”
BackgroundBoland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119 · cited 2×
“…mechanism involved in the three autophagic pathways: chaperone mediated autophagy (CMA), micro- and macroautophagy, and their relevance in ND have been reviewed recently (Boland et al. 2008; Cherra and Chu 2008; Deretic 2008; Levine and Kroemer 2008; Shacka et al. 2008; Todde et al. 2009).”
BackgroundDebris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111 · cited 2×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundS-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury
Cho, D.-H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., & Lipton, S. A. (2009) · Science · doi:10.1126/science.1171091 · Cited by 1,092 · cited 1×
“S-nitrosylation of dynaminrelated proetin 1 (Drp1) that is increased in AD brains, mediates Ab-related mitochondrial fission and neuronal injury (Cho et al. 2009).”
BackgroundGong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 2×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundCell death by necrosis: towards a molecular definition
Golstein, P., & Kroemer, G. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.001 · Cited by 1,044 · cited 2×
“…an accidental and uncontrolled mode of cell death, which exhibits rapid cell swelling and subsequent rupture of the plasma membrane that, due to an inflammatory response, usually induces substantial secondary cell damage in the surrounding tissue (Golstein and Kroemer 2007; Henriquez et al. 2008).”
BackgroundSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · cited 2×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundNagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · cited 1×
“Thus, BDNF exerts protectional effects on cortical neuronal circuitry involving AD, acting through amyloid-independent mechanisms (Nagahara et al. 2009), indicating a prominent role of nerve growth factor (NGF) in both the etiology and treatment of AD.”
BackgroundNeurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 4×
“Almost all HSPs, classified into six main families on the basis of their molecular mass, function as molecular chaperones, and the number of diseases that are known to be caused by their mutations are increasing (Muchowski and Wacker 2005).”
BackgroundInfluentialMitochondrial fragmentation in neurodegeneration.
Knott, A. B., Perkins, G., Schwarzenbacher, R., & Bossy-Wetzel, E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2417 · Cited by 1,002 · cited 1×
“Impaired bioenergetics and dysfunction of mitochondrial energy metabolism lead to reduced ATP production, impaired calcium buffering, and generation of ROS, representing a ‘‘deadly triad in neurodegeneration’’ (Celsi et al. 2009; Knott et al. 2008).”
BackgroundCellular Defenses against Unfolded Proteins
Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 991 · cited 2×
“In addition to showing common morphological and chemical features, the inclusion bodies co-localize with several other proteins that are not structural elements of abnormal fibers, but are binding to them, including various hallmark chaperones and components of the UPS protein implicated in cellular responses, associa…”
BackgroundHitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989 · cited 2×
“Stimulation of death receptors by agonists such as FasL and TNFalpha activates apoptotic cell death in apoptoticcompetent conditions or a type of necrotic cell death dependent on RIP1 kinase, termed necroptosis, in apoptotic-deficient conditions (Hitomi et al. 2008).”
BackgroundThe endoplasmic reticulum and the unfolded protein response
Malhotra, J. D., & Kaufman, R. J. (2007) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.09.003 · Cited by 986 · cited 1×
“ER stress has been suggested to be involved in some human neuronal diseases, such as AD, Parkinson’s disease (PD), prion diseases, etc. (Malhotra and Kaufman 2007).”
BackgroundA Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins
Alberti, S., Halfmann, R., King, O., Kapila, A., & Lindquist, S. (2009) · Cell · doi:10.1016/j.cell.2009.02.044 · Cited by 968 · cited 1×
“A new systemic approach for the discovery of new prions expands the spectrum of this biological functioning (Alberti et al. 2009).”
BackgroundMacroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967 · cited 1×
“Although autophagy has been linked to models of AD, there is no evidence that this is part of a cell death pathway (Yu et al. 2005).”
BackgroundCogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · cited 1×
“…(miRNAs), brain-enriched, small noncoding RNAs that participate in RNA translational and protein expression regulation, has been emphasized, suggesting their involvement in the emergence or progression of NDDs (Bushati and Cohen 2008; Nelson et al. 2008), including AD (Cogswell et al. 2008).”
BackgroundThe PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885 · cited 2×
“Parkin plays a role in maintaining mitochondrial homeostasis, improves mitochondrial dysfunction, regulates their remodeling, promotes their autophagy, promotes DNA repair, and protects against genotoxicity (Kao 2009; Mitsui et al. 2008; Narendra et al. 2008; Park et al. 2009; Poole et al. 2008; Van Laar and Berman 20…”
BackgroundMitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883 · cited 3×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundER stress and neurodegenerative diseases
Lindholm, D., Wootz, H., & Korhonen, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401778 · Cited by 882 · cited 1×
“The exact contributions to and casual effects of ER stress and the proteins involved, however, are poorly understood (Lindholm et al. 2006).”
BackgroundInitiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 3×
“The mechanism by which aSyn, tau, and Ab protein make fibrils is an example of conformational plasticity, because these polypeptides can visit a coil or helical structure, but otherwise they convert into a pathogenic b-sheet structure highly suitable for polymerization and fiber formation (Cairns et al. 2004; Cookson…”
BackgroundProteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Morimoto, R. I. (2008) · Genes & Development · doi:10.1101/gad.1657108 · Cited by 872 · cited 1×
“The decline in biosynthetic and repair activities that compromises the integrity of the proteome is influenced strongly by genes that control aging, thus linking stress and protein homeostasis with the health and life span of the organism (Morimoto 2008).”
BackgroundOxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867 · cited 4×
“Oxidative stress (OS) occurs when the production of free radicals or their products are in excess of antioxidant defense mechanisms (Sayre et al. 2008).”
BackgroundInfluentialCell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863 · cited 1×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundDJ‐1 has a role in antioxidative stress to prevent cell death
Taira, T., Saito, Y., Niki, T., Iguchi‐Ariga, S. M. M., Takahashi, K., & Ariga, H. (2004) · EMBO reports · doi:10.1038/sj.embor.7400074 · Cited by 853 · cited 1×
“Genetic studies have implicated OS in PD pathogenesis (Kim et al. 2005; Martinat et al. 2004; Taira et al. 2004).”
BackgroundMicroglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843 · cited 1×
“…activation and corresponding DAergic terminal loss in the affected nigrostriatal pathway in early PD supports that neuroinflammatory responses by intrinsic microglia contribute to the progressive degeneration in PD and related diseases (Kim and Joh 2006; Ouchi et al. 2005; Wilms et al. 2007).”
BackgroundUbiquitin and ubiquitin-like proteins as multifunctional signals
Welchman, R. L., Gordon, C., & Mayer, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1700 · Cited by 828 · cited 3×
“Ubiquitination has a central role in signal transduction to rival and complement protein phosphorylation (Welchman et al. 2005) and synaptic plasticity (Hegde 2004), while Ub-binding domains (UBD) are relevant to the DNA damage response, acting to restore normal transcription after DNA damage (Daulnyand Tansey 2009; H…”
BackgroundWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821 · cited 1×
“Progression of ND is thought to be driven by uncontrolled inflammation (Gao and Hong 2008).”
BackgroundBancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818 · cited 3×
“…detected in more than 50% of hippocampal neurons showing granulovacuolar degeneration, often co-localized with tau, suggesting a ‘‘pretangle’’ stage (Bancher et al. 1989), and the demonstration of elevated casein kinase 1 (CK-1) in both granulovacuolar bodies and NFT-bearing neurons and the…”
BackgroundSelf-citationMitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783 · cited 1×
“Mitochondrial alterations and OS are important parts of the multifactorial pathogenic process of PD (Henchcliffe and Beal 2008; Muqit et al. 2006; Onyango 2008; Schapira 2008; Vila et al. 2008).”
BackgroundPraticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · cited 4×
“In both human AD and transgenic (tg) mouse models of AD, oxidative damage occurs preceding Ab deposition that further contributes to OS and ND (Butterfield and BoydKimball 2004; Pratico et al. 2001; Sonnen et al. 2008).”
BackgroundInfluentialThe axonal transport of mitochondria
Hollenbeck, P. J., & Saxton, W. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02745 · Cited by 771
Xu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757 · cited 2×
“aSyn selectively interacts with the chaperone 14-3-3 in SN leading to a decrease of its available levels to inhibit apoptosis (Xu et al. 2002), while tyrosine hydroxylase (TH) activity is stimulated by 14-3-3, and inhibited by aSyn (Perez et al.”
BackgroundMattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751 · cited 1×
“…systems are compromised resulting in synaptic dysfunction, impaired plasticity and ND. OS, perturbated energy metabolism, and aggregation of disease-related proteins adversely affect Ca2? homeostasis by mechanisms that have been elucidated recently (Marambaud et al. 2009; Mattson 2007).”
BackgroundPicomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740
Role of Axonal Transport in Neurodegenerative Diseases
De Vos, K. J., Grierson, A. J., Ackerley, S., & Miller, C. C. J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.061307.090711 · Cited by 738 · cited 2×
“There is growing evidence that defective neuronal and axonal transport play a mechanistic role in several NDDs (De Vos et al. 2008; Roy et al. 2005).”
BackgroundCaspase-independent cell death
Kroemer, G., & Martin, S. J. (2005) · Nature Medicine · doi:10.1038/nm1263 · Cited by 716 · cited 1×
“Such alternative strategies may either target catabolic hydrolases or aimed at preventing mitochondrial membrane permeabilization and its upstream triggers (Kroemer and Martin 2005).”
BackgroundNeurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715 · cited 4×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundInfluentialα-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714 · cited 1×
“Mitochondrial aSyn dose-dependently down-regulates complex I activity, in vitro impairs mitochondrial function and leads to increased OS (Hsu et al. 2000; Liu et al. 2009).”
BackgroundCurrent hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703 · cited 5×
“Current hypothesis for the underlying pathobiology of ALS include oxidase damage, accumulation of intracellular aggregates (SOD1, TDP-43), implying abnormal RNA metabolism, mitochondrial dysfunction, defects in axonal transport, growth factor deficiency, astroglial pathology, and glutamate excitotoxicity (Rothstein 20…”
BackgroundInfluentialAutophagy: A lysosomal degradation pathway with a central role in health and disease
Eskelinen, E.-L., & Saftig, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.014 · Cited by 703 · cited 1×
“Proteins are transferred to the lysosomal membrane and, through binding to a receptor lysosome-associated membrane protein (autophagosome), they are translocated into the lysosomal lumen and degraded (Eskelinen and Saftig 2009) (Fig.”
BackgroundKim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501282102 · Cited by 701 · cited 1×
“Genetic studies have implicated OS in PD pathogenesis (Kim et al. 2005; Martinat et al. 2004; Taira et al. 2004).”
BackgroundApoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698 · cited 2×
“…(TUNEL/ISL staining associated with the expression of apoptosis-related proteins (ARPs), oncogenes, and other detectable player involved in the cascade of PCD), have reported variable incidence of apoptotic cell death in NDDs (Fadeel and Orrenius 2005; Jellinger 2006, 2007a, b; Kermer et al. 2004).”
BackgroundA network dysfunction perspective on neurodegenerative diseases
Palop, J. J., Chin, J., & Mucke, L. (2006) · Nature · doi:10.1038/nature05289 · Cited by 692 · cited 2×
“The causes of this prolonged process due to progressive damage of specific vulnerable brain regions or neuronal networks before clinical manifestation are poorly understood (Palop et al. 2006).”
BackgroundProtein aggregation kinetics, mechanism, and curve-fitting: A review of the literature
Morris, A. M., Watzky, M. A., & Finke, R. G. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.016 · Cited by 680 · cited 2×
“If mutations in sequence or changes in environmental conditions lead to partial unfolding of the native state of a protein, it will often aggregate, sometimes into well-defined fibrillar structures (Morris et al. 2009; Ovádi and Orosz 2009).”
BackgroundKim, Y. S., & Joh, T. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.40 · Cited by 655 · cited 2×
“Demonstration of microglial activation and corresponding DAergic terminal loss in the affected nigrostriatal pathway in early PD supports that neuroinflammatory responses by intrinsic microglia contribute to the progressive degeneration in PD and related diseases (Kim and Joh 2006; Ouchi et al. 2005; Wilms et al. 2007…”
BackgroundCell death in the nervous system
Bredesen, D. E., Rao, R. V., & Mehlen, P. (2006) · Nature · doi:10.1038/nature05293 · Cited by 636 · cited 1×
“…of neuronal demise are discussed: apoptosis, a specific form of gene-directed programmed cell death (PCD); (oncotic) necrosis, a passive killing of the cell; and autophagic degeneration [for rev. see (Bredesen et al. 2006; Bredesen 2008; Gorman 2008; Jellinger 2006, 2007a; Okouchi et al. 2007)].”
BackgroundMitochondrial abnormalities in Alzheimer brain: Mechanistic implications
Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., & Gibson, G. E. (2005) · Annals of Neurology · doi:10.1002/ana.20474 · Cited by 622 · cited 1×
“In AD, there is a large body of evidence implicating impaired energy metabolism and oxidative damage (Bubber et al. 2005; Lin and Beal 2006).”
BackgroundTownsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618 · cited 2×
“The presence of ubiquitinating and proteolytic enzymes and other cytoskeletal elements in LBs indicates that these inclusions could be specialized aggresome-related structures as a means of controlling excessive levels of abnormal proteins (Chen and Feany 2005).”
BackgroundInvolvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611 · cited 2×
“RNA is extensively modified in AD and, while clearly damaged, its rapid turnover may also serve a protective function (Nunomura et al. 2006, 2009).”
BackgroundAutophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Korolchuk, V. I., Mansilla, A., Menzies, F. M., & Rubinsztein, D. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.021 · Cited by 610 · cited 2×
“Emerging evidence supports the view that induction of autophagy is a neuroprotective process and that inadequate or defective autophagy, rather than excessive autophagy, compromises degradation of UPS substrates and, thus, promotes cell death (Korolchuk et al. 2009; Nixon 2006).”
BackgroundNeumann, M., Kwong, L. K., Lee, E. B., Kremmer, E., Flatley, A., Xu, Y., Forman, M. S., Troost, D., Kretzschmar, H. A., Trojanowski, J. Q., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0477-9 · Cited by 604 · cited 2×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundThe Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600 · cited 1×
“Recent data show that the UPR is activated in pretangle neurons in AD hippocampus (Hoozemans et al. 2009) and increased levels of several molecular chaperones in cytologically normal appearing neurons suggest an early role for the UPR (Macario and Conway de Macario 2007).”
BackgroundA Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 2×
“2002), while tyrosine hydroxylase (TH) activity is stimulated by 14-3-3, and inhibited by aSyn (Perez et al. 2002).”
BackgroundKramer, M. L., & Schulz-Schaeffer, W. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-06.2007 · Cited by 571 · cited 2×
“suggests a severe pathologic impact on synaptic functions leading to ND, implicating PD as a synaptopathy (Kramer and Schulz-Schaeffer 2007).”
BackgroundNeuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 567 · cited 6×
“…assembles into highly soluble special oligomers that proceed to insoluble aggregates (Sharon et al. 2003); it is potentially prone to misfold (Uversky 2007) and may lead to neuronal death (Kazantsev and Kolchinsky 2008), but also other modes of toxicity have been proposed (Waxman and Giasson…”
BackgroundInfluentialSharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00024-2 · Cited by 562 · cited 2×
“2). aSyn assembles into highly soluble special oligomers that proceed to insoluble aggregates (Sharon et al. 2003); it is potentially prone to misfold (Uversky 2007) and may lead to neuronal death (Kazantsev and Kolchinsky 2008), but also other modes of toxicity have been proposed (Waxman and…”
BackgroundRole of brain-derived neurotrophic factor in Huntington's disease
ZUCCATO, C., & CATTANEO, E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 552 · cited 1×
“This indicates that, in addition to the reduction in BDNF mRNA, there is also unbalanced neurotrophic receptor signaling in HD (Zuccato and Cattaneo 2007; Zuccato et al. 2008).”
BackgroundExpansion and evolution of cell death programmes
Degterev, A., & Yuan, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2393 · Cited by 551 · cited 1×
“Recent data point to the existence of multiple nonapoptotic, regulated cell death mechanisms, some of which overlap or are mutually exclusive with apoptosis (Degterev and Yuan 2008).”
BackgroundProtein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
Irvine, G. B., El-Agnaf, O. M., Shankar, G. M., & Walsh, D. M. (2008) · Molecular Medicine · doi:10.2119/2007-00100.irvine · Cited by 550 · cited 2×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundDeane, R., Bell, R., Sagare, A., & Zlokovic, B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 548 · cited 1×
“In AD, RAGE levels of the BBB are increased and low-density lipoprotein receptor related protein-1 (LRP1) levels at the BBB and the capacity of soluble LRP1 (sLRP1) to bind peripheral Ab are reduced, forcing Ab accumulation in the brain (Deane et al. 2009).”
BackgroundThe role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
Pan, T., Kondo, S., Le, W., & Jankovic, J. (2008) · Brain · doi:10.1093/brain/awm318 · Cited by 546 · cited 2×
“assumption that the ALP may be related to the development of PD (Pan et al. 2008; Engelender 2008).”
BackgroundLinking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 2×
“In a ‘‘dual pathway’’ of causality, Ab and tau can be linked by separate mechanisms driven by common upstream driver (Small and Duff 2008).”
BackgroundTargeting programmed cell death in neurodegenerative diseases
Vila, M., & Przedborski, S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1100 · Cited by 546 · cited 1×
“However, caspase-independent cell death also exists (Vila and Przedborski 2003).”
Environmental toxicity, oxidative stress and apoptosis: Ménage à Trois
Franco, R., Sánchez-Olea, R., Reyes-Reyes, E. M., & Panayiotidis, M. I. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.11.012 · Cited by 541 · cited 2×
“…levels, mitochondrial dysfunction, withdrawal of neurotrophic support, glutamate receptor stimulation, OS, NO release, and environmental stressors (Franco et al. 2009), each demonstrating specificity of function, regulation and pathway involvement, influenced by subtle differences among cell…”
BackgroundUbiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Tai, H.-C., & Schuman, E. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2499 · Cited by 532 · cited 8×
“Proteins that remain unfolded are degraded not only by the UPS, and the phagosome–lysosome system (Tai and Schuman 2008) or autophagy with three major pathways: chaperone-mediated autophagy (CMA), micro- and macroautophagy (Todde et al. 2009) (Fig.”
BackgroundInfluentialThe apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death
González-Polo, R.-A., Boya, P., Pauleau, A.-L., Jalil, A., Larochette, N., Souquère, S., Eskelinen, E.-L., Pierron, G., Saftig, P., & Kroemer, G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02447 · Cited by 524 · cited 5×
“Neuronal cell death may exhibit morphologic features of autophagy or necrosis, which differ from that of canonical apoptosis or autophagic vacuolation can precede apoptotic cell death; this argues against the clear distinction between apoptotic and autophagic cell death (ACD) (Gonzalez-Polo et al. 2005; Uchiyama et al…”
BackgroundInfluentialCell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 4×
“2009) and recent evidence that NFTs in experimental models do not directly correlate with neuron loss (Andorfer et al. 2005; SantaCruz et al. 2005) suggests that affected neurons may be able to withhold NFT formation for a long time before they degenerate.”
BackgroundInfluentialBennett, E. J., Bence, N. F., Jayakumar, R., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 509 · cited 2×
“Ubiquitinated protein aggregates provide a nuclear center for the formation of inclusion bodies, but there are several differences that distinguish these inclusions, some being aggregated in the cytoplasm, others are prevalent in the nucleus (Bennett et al. 2005; Woulfe 2007).”
BackgroundHsp70 Reduces α-Synuclein Aggregation and Toxicity
Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., & McLean, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400255200 · Cited by 508 · cited 1×
“It decreased insoluble high-molecular synuclein and suppressed its toxicity, suggesting that HSP 70 and others may have protective roles (Klucken et al. 2004). aSyn selectively interacts with the chaperone 14-3-3 in SN leading to a decrease of its available levels to inhibit apoptosis (Xu et al.…”
BackgroundToxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria
Liu, J., Lillo, C., Jonsson, P. A., Velde, C. V., Ward, C. M., Miller, T. M., Subramaniam, J. R., Rothstein, J. D., Marklund, S., Andersen, P. M., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.016 · Cited by 506 · cited 1×
“Expression of mutant SOD1 in cell cultures leads to mitochondrial dysfunction, and mice expressing the G9eA SOD1 mutation develop mitochondrial energy dysfunction in spinal cord and brain, with severely compromised ATP synthesis (Liu et al. 2004).”
BackgroundThe Aggregation and Fibrillation of α-Synuclein
Fink, A. L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050073t · Cited by 501 · cited 1×
“The fact that the transient oligomers disappear at the same rate that fibrils appear suggests that these may be assembled directly from them via a longitudinal association of the oligomers (Fink 2006).”
BackgroundGlobal changes to the ubiquitin system in Huntington's disease
Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K.-Y., Zaitseva, T. S., Becker, C. H., Bates, G. P., Schulman, H., & Kopito, R. R. (2007) · Nature · doi:10.1038/nature06022 · Cited by 497 · cited 2×
“HD is linked to global changes in the UPS to a much greater extent than previously recognized, but the global status of the system in HD brain is not yet fully elucidated (Bennett et al. 2007; Ortega et al. 2007).”
BackgroundWyllie, A. H. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011623 · Cited by 497
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Schwartz, A. L., & Ciechanover, A. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.051208.165340 · Cited by 492 · cited 3×
“Proteins are a heterogeneous population of different longlived conformers which, due to their flexibility, are in a dynamic state between various conformational substrates maintained by synthesis and degradation (Schwartz and Ciechanover 2009).”
BackgroundOxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
Barber, S. C., Mead, R. J., & Shaw, P. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.008 · Cited by 474 · cited 2×
“Because only a subset of ALS cases can be attributed to one particular deficit, e.g., mutation of SOD1 of the gene encoding neurofilament H, ALS etiology is likely to be multifactorial, but the precise mechanisms by which SOD1 leads to ND have not been defined (Barber et al. 2006).”
BackgroundMechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471 · cited 2×
“Furthermore, excitotoxicity, DA toxicity, metabolic impairment, mitochondrial dysfunction, OS, apoptosis, and autophagy have been implicated in the progressive degeneration observed in HD (Gil and Rego 2008).”
BackgroundMicroglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · cited 2×
“Microglia activation that may play a major role in the pathogenesis of HD has been shown to correlate with severity of the disease, with a close spatial and temporal relationship to neuronal dysfunction (Pavese et al. 2006; Tai et al. 2007a), and has already been detected in presymptomatic HD gene carriers (Tai et al.”
BackgroundChaperones increase association of tau protein with microtubules
Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P., & Xu, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242720499 · Cited by 461 · cited 1×
“HSP 70 and others interact with hyperphosphorylated tau in human brain, facilitate tau ubiquitination, enhance the levels of insoluble tau, and in vitro suppresses tauinduced cell death (Dou et al. 2003).”
BackgroundCell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., & Wisniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458 · cited 1×
“NFTs involved around 40% of all degenerating neurons, which means a threefold increased risk of degeneration compared to tangle-free neurons (Lassmann et al. 1995).”
BackgroundSelf-citationAlterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome
Shringarpure, R., Grune, T., Mehlhase, J., & Davies, K. J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206279200 · Cited by 441 · cited 2×
“2008), but Ub conjugation is not required for the degradation of oxidated proteins by the proteasome (Shringarpure et al. 2003).”
BackgroundMicroglial activation in presymptomatic Huntington's disease gene carriers
Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440 · cited 1×
“…play a major role in the pathogenesis of HD has been shown to correlate with severity of the disease, with a close spatial and temporal relationship to neuronal dysfunction (Pavese et al. 2006; Tai et al. 2007a), and has already been detected in presymptomatic HD gene carriers (Tai et al. 2007b).”
BackgroundOxidative stress and mitochondrial dysfunction in neurodegenerative diseases
Trushina, E., & McMurray, C. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.056 · Cited by 439 · cited 4×
“2008b), but, there is no clear and defined mechanism showing how OS plays a key role in the regulation of cell survival and death through its interaction with cellular molecules and signal transduction pathways in NDDs (Trushina and McMurray 2007).”
BackgroundInfluentialAxonal transport and neurodegenerative disease
Chevalier-Larsen, E., & Holzbaur, E. L. F. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.04.002 · Cited by 438 · cited 1×
“The first mechanisms have been the subject of intense investigations, but less attention has been focused on the role of the axonal transport in NDDs (Chevalier-Larsen and Holzbaur 2006; De Vos et al. 2008; Roy et al. 2005).”
BackgroundGozuacik, D., & Kimchi, A. (2007) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78006-1 · Cited by 437 · cited 1×
“Due to increasing interest in nonapoptotic PCD forms and the development of mammalian genetic tools to study autophagy, autophagic cell death has achieved major prominence, and is recognized now as a legitimate alternative death pathway to apoptosis (Gozuacik and Kimchi 2007).”
BackgroundNeuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H.-M., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 436 · cited 1×
“The pattern of humoral immune reactivity is consistent with an immune activation of microglia leading to the targeting of DA nigral neurons for the destruction in both idiopathic and genetic cases of PD (Gao et al. 2008; Orr et al. 2005).”
BackgroundStadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Brück, W., Jellinger, K., & Lassmann, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 428 · cited 4×
“…with DNA fragmentation particularly in the severely damaged hippocampus, only 0.02–0.05% of neurons display the morphology of apoptosis and show expression of ARPs and of activated caspase 3, the key enzyme of the terminal part of the apoptosis cascade (Louneva et al. 2008; Stadelmann et al. 1999).”
BackgroundInfluentialSelf-citationAggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
Taylor, J. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg074 · Cited by 426 · cited 1×
“However, it is not clear whether aggresome formation is causative or protective, although data suggested that they serve a cytoprotective function, facilitating the degradation of toxic proteins (Taylor et al. 2003).”
BackgroundNEURODEGENERATIVE DISEASES: New Concepts of Pathogenesis and Their Therapeutic Implications
Skovronsky, D. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100113 · Cited by 425 · cited 4×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundInfluentialA new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia
Tomiyama, T., Nagata, T., Shimada, H., Teraoka, R., Fukushima, A., Kanemitsu, H., Takuma, H., Kuwano, R., Imagawa, M., Ataka, S., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21321 · Cited by 421 · cited 1×
“…and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan et al. 2007; Salminen et al. 2008; Selkoe 2008; Simoneau et al. 2007; Skovronsky et al. 2006; Soto and Estrada 2008; Standridge 2006; Tomiyama et al. 2008).”
BackgroundWilcock, D. M., Rojiani, A. M., Rosenthal, A., Subbarao, S., Freeman, M. J., Gordon, M. N., & Morgan, D. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-24 · Cited by 420
Higashi, S., Iseki, E., Yamamoto, R., Minegishi, M., Hino, H., Fujisawa, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.048 · Cited by 419
Protein‐misfolding diseases and chaperone‐based therapeutic approaches
Chaudhuri, T. K., & Paul, S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05181.x · Cited by 419 · cited 2×
“The role of molecular, chemical and pharmacological chaperones in suppressing the effect of protein misfolding-induced consequences in humans has been explained (Chaudhuri and Paul 2006).”
Backgroundα-Synuclein and neuronal cell death
Cookson, M. R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-9 · Cited by 418 · cited 1×
“Although the process is mysterious, the prime suspect for a toxic protein is aSyn and its aberrant forms, including increased expression of the normal gene (Cookson 2009).”
BackgroundAβ40 Inhibits Amyloid Deposition In Vivo
Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., & McGowan, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4849-06.2007 · Cited by 415 · cited 1×
“This was shown in cellular models (Kumar-Singh et al. 2006) and in mouse models when increased levels of Ab-40 in brain while keeping the Ab-42 level decreased plaque burden (Kim et al. 2007).”
BackgroundN-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & RAYMOND, L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 413 · cited 1×
“In addition to mitochondrial dysfunction, excitotoxic neuronal death related to altered NMDA receptor function induced by mhtt is an important factor in the pathogenesis of HD (Cowan and Raymond 2006; Estrada Sanchez et al. 2008; Fan and Raymond 2007).”
BackgroundZhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E. B., Xie, S. X., Joyce, S., Li, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406361102 · Cited by 413 · cited 2×
“Parkin deficiency increases vulnerability to inflammation-related nigral degeneration (Frank-Cannon et al. 2008), while human neuromelanin induces neuroinflammation and degeneration in the rat SN (Zecca et al. 2008) and aggregated aSyn activates microglia (Zhang et al. 2005b).”
BackgroundOxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia
Calabrese, V., Lodi, R., Tonon, C., D'Agata, V., Sapienza, M., Scapagnini, G., Mangiameli, A., Pennisi, G., Stella, A. M. G., & Butterfield, D. A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.012 · Cited by 406 · cited 1×
“Conditions of stress are characterized by a robust increase in the synthesis of heat shock proteins (HSPs) that are crucial for recovery from stress-induced protein damage (Calabrese et al. 2005).”
BackgroundBrecht, W. J., Harris, F. M., Chang, S., Tesseur, I., Yu, G.-Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4315-03.2004 · Cited by 403 · cited 2×
“increases tau phosphorylation in mice (Brecht et al. 2004), suggesting a neuron-specific effect of ApoE4 on tau phosphorylation.”
BackgroundThe two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases
Winklhofer, K. F., Tatzelt, J., & Haass, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601930 · Cited by 401 · cited 1×
“In this case, the loss of function may be accompanied by a gain-of-function (GOF) pathogenesis, which in many cases determines the pathological and clinical features (Agnati et al. 2008; Winklhofer et al. 2008).”
BackgroundApoptosis in Parkinson's disease: Signals for neuronal degradation
Tatton, W. G., Chalmers-Redman, R., Brown, D., & Tatton, N. (2003) · Annals of Neurology · doi:10.1002/ana.10489 · Cited by 397 · cited 1×
“Whether PCD actually occurs within the human PD brain remains controversial, and this possibility has been neither confirmed by numerous studies nor definitely excluded (Jellinger 2006; Tatton et al. 2003).”
ResultColocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies
Ishizawa, T., Mattila, P., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 394 · cited 16×
“In a genetic mouse model of PD, 26S proteasomal dysfunction in SN neurons triggers ND of the nigrostriatal pathway, and intraneuronal Lewy-like inclusions containing aSyn and Ub in surviving neurons show mitochondria similar to those in early forms of LBs (pale bodies) in PD patients.”
BackgroundInfluentialParkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
Xiong, H., Wang, D., Chen, L., Choo, Y. S., Ma, H., Tang, C., Xia, K., Jiang, W., Ronai, Z., Zhuang, X., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37617 · Cited by 392 · cited 1×
“…complex consisting of early-onset familial PD associated Parkin, PINK-1 (also known as PARK-6) and DJ-1 (PARK-7) mutations promotes degradation of un- or mis-folded proteins and may constitute a pathogenic mechanism for recessive forms of inherited PD (Li and Guo 2009; Xiong et al. 2009).”
BackgroundAβ inhibits the proteasome and enhances amyloid and tau accumulation
Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., & LaFerla, F. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.014 · Cited by 384 · cited 2×
“In AD, Ab inhibits the proteasome and enhances amyloid and tau accumulation (Oddo 2008; Tseng et al. 2008), while ionic liquids promote amyloid formation from aSyn (Hwang et al.”
BackgroundAxonal transport defects: a common theme in neurodegenerative diseases
Roy, S., Zhang, B., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0952-x · Cited by 372 · cited 6×
“The first mechanisms have been the subject of intense investigations, but less attention has been focused on the role of the axonal transport in NDDs (Chevalier-Larsen and Holzbaur 2006; De Vos et al. 2008; Roy et al. 2005).”
BackgroundInfluentialFrataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity
Bulteau, A.-L., O'Neill, H. A., Kennedy, M. C., Ikeda-Saito, M., Isaya, G., & Szweda, L. I. (2004) · Science · doi:10.1126/science.1098991 · Cited by 372 · cited 1×
“Accumulation of mitochondrial iron may lead to impaired oxidative phosphorylation, loss of mtDNA, increase in iron and OS (Bulteau et al. 2004).”
BackgroundNeurons May Live for Decades with Neurofibrillary Tangles
Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370 · cited 9×
“That, given the robust survivals of neurons with NFTs (Morsch et al. 1999; Schwab et al. 2009) and recent evidence that NFTs in experimental models do not directly correlate with neuron loss (Andorfer et al.”
BackgroundInfluentialIron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1010 · Cited by 369 · cited 2×
“…2005) and Friedreich ataxia (FRDA) are associated with mutations in genes that encode proteins involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by AD and PD (Altamura and Muckenthaler 2009; Gerlach et al. 2006; Linert et al. 2006; Zecca et al. 2004).”
BackgroundMartinat, C., Shendelman, S., Jonason, A., Leete, T., Beal, M. F., Yang, L., Floss, T., & Abeliovich, A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020327 · Cited by 364 · cited 1×
“Genetic studies have implicated OS in PD pathogenesis (Kim et al. 2005; Martinat et al. 2004; Taira et al. 2004).”
BackgroundNeuronal cell death in neurodegenerative diseases: recurring themes around protein handling
Gorman, A. M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00402.x · Cited by 362 · cited 6×
“2009), each demonstrating specificity of function, regulation and pathway involvement, influenced by subtle differences among cell phenotypes (Gorman 2008; Ribe et al. 2008).”
BackgroundInfluentialReddy, P. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03530.x · Cited by 358 · cited 2×
“Mutant APP and its derivates are involved in the generation of free radicals in mitochondria and cause mitochondrial oxidative damage, linking Ab, generation of free radicals, and oxidative damage in the pathogenesis of AD (Reddy 2006).”
BackgroundStructural Characterization of a Soluble Amyloid β-Peptide Oligomer
Yu, L., Edalji, R., Harlan, J. E., Holzman, T. F., Lopez, A. P., Labkovsky, B., Hillen, H., Barghorn, S., Ebert, U., Richardson, P. L., et al. (2009) · Biochemistry · doi:10.1021/bi802046n · Cited by 354 · cited 5×
“6 Huntingtin Choreoacanthocytosis (neuroacanthocytosis) CHAC (VPS13A) 9q21 Chorein Spinocerebellar ataxias (SCA), hereditary SCA 1–19, CACNA-1, TBP 3, 6, 8, 11, 12, 14, 19, 22 Ataxin 1–17 Friedreich ataxia (FRDA) PFRDA-1 (FXN) 9q13 Frataxin (GAA [ 66) Machado–Joseph disease (MJD) ? spinocellular ataxia (SCA) type 2 MJ…”
BackgroundInfluentialMetals and amyloid‐β in Alzheimer's disease
Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., & Li, Q. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00434.x · Cited by 353 · cited 4×
“In AD, aberrant metal homeostasis may contribute to the formation of ROS and toxic Ab oligomers, thus, facilitating the formation of amyloid plaques (Maynard et al. 2005) and increased lipid peroxidation precedes Ab plaque formation in an animal model of AD (Pratico et al.”
BackgroundInfluentialThe ubiquitylation machinery of the endoplasmic reticulum
Hirsch, C., Gauss, R., Horn, S. C., Neuber, O., & Sommer, T. (2009) · Nature · doi:10.1038/nature07962 · Cited by 352 · cited 2×
“…transported to perinuclear microtubule-organizing centers (centrosomes), where they are encapsulated by intermediary filaments to form large structures called aggresomes, sites of enhanced proteolysis, serving to protect from exposure to cytotoxic effects of abnormal proteins (Hirsch et al. 2009).”
BackgroundProtein Misfolding and Neurodegeneration
Soto, C., & Estrada, L. D. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.56 · Cited by 352 · cited 5×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundInfluentialCalcium signaling in neurodegeneration
Marambaud, P., Dreses-Werringloer, U., & Vingtdeux, V. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-20 · Cited by 352 · cited 1×
“…systems are compromised resulting in synaptic dysfunction, impaired plasticity and ND. OS, perturbated energy metabolism, and aggregation of disease-related proteins adversely affect Ca2? homeostasis by mechanisms that have been elucidated recently (Marambaud et al. 2009; Mattson 2007).”
BackgroundInducible Expression of Tau Repeat Domain in Cell Models of Tauopathy
Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen, M., Gazova, Z., Mandelkow, E., & Mandelkow, E.-M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507753200 · Cited by 351 · cited 2×
“Oligomeric and pre-aggregated forms of tau protein have been shown to be toxic in vitro (Khlistunova et al. 2006), but the mechanisms underlying its structural changes leading to human tauopathies still remain elusive (Brunden et al. 2008; Sahara et al. 2008).”
BackgroundAutophagy and the ubiquitin-proteasome system: Collaborators in neuroprotection
Nedelsky, N. B., Todd, P. K., & Taylor, J. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.002 · Cited by 351 · cited 1×
“Both were implicated to play important roles in the pathogenesis of NDDs (McCray and Taylor 2008), but also to collaborate in neuroprotection (Nedelsky et al. 2008).”
BackgroundNeuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351 · cited 2×
“…and blood–brain-barrier (BBB) dysfunction are prominent pathological features in the pathogenesis and progression of NDDs including AD (Appel 2009; Eikelenboom et al. 2006; McGeer and McGeer 2005; Rojo et al. 2008; Schwab and McGeer 2008; Stolp and Dziegielewska 2009; Zilka et al. 2009).”
BackgroundA possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M. (2005) · Brain · doi:10.1093/brain/awh625 · Cited by 350 · cited 1×
“The pattern of humoral immune reactivity is consistent with an immune activation of microglia leading to the targeting of DA nigral neurons for the destruction in both idiopathic and genetic cases of PD (Gao et al. 2008; Orr et al. 2005).”
BackgroundFinder, V. H., & Glockshuber, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000100355 · Cited by 348 · cited 1×
“Of these, the most toxic species appear to be small Ab oligomers (Finder and Glockshuber 2007).”
BackgroundMolecular Mechanisms and Pathophysiology of Necrotic Cell Death
Vanlangenakker, N., Berghe, T., Krysko, D., Festjens, N., & Vandenabeele, P. (2008) · Current Molecular Medicine · doi:10.2174/156652408784221306 · Cited by 347 · cited 19×
“2009)], while common players in necrotic cell death, irrespective of the stimulus, are calcium and ROS (Vanlangenakker et al. 2008).”
BackgroundInfluentialSalminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 346 · cited 1×
“It has been discussed whether AD pathology could be the outcome of the innate immunity defense in the brain (Salminen et al. 2009).”
BackgroundPhosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies
Arai, T., Mackenzie, I. R. A., Hasegawa, M., Nonoka, T., Niizato, K., Tsuchiya, K., Iritani, S., Onaya, M., & Akiyama, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0480-1 · Cited by 345 · cited 1×
“…et al. 2003; Shao et al. 2006) and the co-occurrence of abnormal deposition of tau, aSyn and TDP-43 in AD, DLB and other NDDs, probably related to genetic factors (Arai et al. 2009; Higashi et al. 2007), highlight the interface between these two and other misfolded proteins (Soto and Estrada 2008).”
BackgroundThe Relevance of Iron in the Pathogenesis of Parkinson's Disease
GÖTZ, M. E., DOUBLE, K., GERLACH, M., YOUDIM, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342
Polyglutamine neurodegeneration: protein misfolding revisited
Williams, A. J., & Paulson, H. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.004 · Cited by 341 · cited 3×
“The ‘‘toxic oligomer’’ hypothesis is supported by the finding that a single-domain antibody can recognize a common conformational epitope that is displayed by several disease-associated proteins, including b-amyloid (Ab), a-synuclein (aSyn), tau protein, prions, and polyglutamine (polyQ) containing peptides (Hernandez…”
BackgroundIron misregulation in the brain: a primary cause of neurodegenerative disorders
Ke, Y., & Qian, Z. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00353-3 · Cited by 340
Neurotrophic factors in Alzheimer’s disease: role of axonal transport
Schindowski, K., Belarbi, K., & Buée, L. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00378.x · Cited by 335 · cited 3×
“…TUNEL-positive neurons and ultrastructural features of both apoptosis and necrosis, but no activated caspases were observed (Andorfer et al. 2005; Schindowski et al. 2008b), while in aging PS/APP mice a crosstalk between apoptosis and autophagy was identified, which influences neuronal survival…”
BackgroundMicroglia and Alzheimer's disease pathogenesis
Streit, W. J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20093 · Cited by 335 · cited 2×
“…(IL-1-a and -b, IL-6), tumor necrosis factor-a (TNF-a), monocyte chemoattractant protein-qmRN, ab-macroglobulin, and complement proteins, part of which are localized in the Ab plaques and in the surrounding activated astrocytes and microglia (Block et al. 2007; Schwab and McGeer 2008; Streit 2004).”
BackgroundLRRK2 regulates synaptic vesicle endocytosis
Shin, N., Jeong, H., Kwon, J., Heo, H. Y., Kwon, J. J., Yun, H. J., Kim, C.-H., Han, B. S., Tong, Y., Shen, J., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.015 · Cited by 329 · cited 3×
“Fulllength leucine-rich repeat kinase 2 (LRRK2), that regulates synaptic vesicle endocytosis (Shin et al. 2008), is not a”
BackgroundBiophysical characterization of intrinsically disordered proteins
Eliezer, D. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.004 · Cited by 328 · cited 3×
“Many proteins associated with NDDs are intrinsically disordered under physiological conditions (Eliezer 2009b; Uversky 2009).”
BackgroundBedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327 · cited 2×
“This demonstrates a direct link between dysfunction of the UPS and the neuropathology of PD and that 26S proteasome activity may maintain neuronal homeostasis (Bedford et al. 2008a).”
BackgroundHay, D. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh144 · Cited by 327 · cited 1×
“In polyQ diseases, the effect of chaperones can inhibit or delay htt aggregates, thus modulating ND in various animal models (Hay et al. 2004; Kimura and Kakizuka 2003).”
BackgroundMicroRNAs (miRNAs) in Neurodegenerative Diseases
Nelson, P. T., Wang, W., & Rajeev, B. W. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00120.x · Cited by 326 · cited 2×
“…(miRNAs), brain-enriched, small noncoding RNAs that participate in RNA translational and protein expression regulation, has been emphasized, suggesting their involvement in the emergence or progression of NDDs (Bushati and Cohen 2008; Nelson et al. 2008), including AD (Cogswell et al. 2008).”
BackgroundParkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 325 · cited 1×
“Co-localization of aSyn and parkin within LBs suggests that parkin plays a role in ubiquitination and posttranslational modification of aSyn (Schlossmacher et al. 2002).”
BackgroundKumar-Singh, S., Theuns, J., Van Broeck, B., Pirici, D., Vennekens, K., Corsmit, E., Cruts, M., Dermaut, B., Wang, R., & Van Broeckhoven, C. (2006) · Human Mutation · doi:10.1002/humu.20336 · Cited by 323 · cited 2×
“This was shown in cellular models (Kumar-Singh et al. 2006) and in mouse models when increased levels of Ab-40 in brain while keeping the Ab-42 level decreased plaque burden (Kim et al.”
BackgroundMitochondria, calcium and cell death: A deadly triad in neurodegeneration
Celsi, F., Pizzo, P., Brini, M., Leo, S., Fotino, C., Pinton, P., & Rizzuto, R. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.02.021 · Cited by 323 · cited 1×
“Impaired bioenergetics and dysfunction of mitochondrial energy metabolism lead to reduced ATP production, impaired calcium buffering, and generation of ROS, representing a ‘‘deadly triad in neurodegeneration’’ (Celsi et al. 2009; Knott et al. 2008).”
BackgroundParavastu, A. K., Qahwash, I., Leapman, R. D., Meredith, S. C., & Tycko, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812033106 · Cited by 322 · cited 2×
“…that the predominant molecular structure of in brain seeded Ab fibrils differs from that of purely synthetic Ab-40 fibrils, which probably allows a new approach to detailed structural characterization of Ab fibrils and their possible correlation with neurodegeneration in AD (Paravastu et al. 2009).”
BackgroundDCTN1 mutations in Perry syndrome
Farrer, M. J., Hulihan, M. M., Kachergus, J. M., Dächsel, J. C., Stoessl, A. J., Grantier, L. L., Calne, S., Calne, D. B., Lechevalier, B., Chapon, F., et al. (2009) · Nature Genetics · doi:10.1038/ng.293 · Cited by 320 · cited 1×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundMitochondrial alterations in Alzheimer's disease
Baloyannis, S. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9204 · Cited by 318 · cited 1×
“Morphological, biochemical and genetic abnormalities of the mitochondria in several AD tissues have been reported, which often do not coexist with cytoskeletal pathology and accumulation of Ab deposits (Baloyannis 2006).”
BackgroundConsequence of Aβ immunization on the vasculature of human Alzheimer's disease brain
Boche, D., Zotova, E., Weller, R. O., Love, S., Neal, J. W., Pickering, R. M., Wilkinson, D., Holmes, C., & Nicoll, J. A. R. (2008) · Brain · doi:10.1093/brain/awn261 · Cited by 316 · cited 4×
“Keywords Neurodegeneration Classification of proteinopathies Pathogenic factors Oxidative stress Bioenergetic deficiency Mitochondrial defects Neuronal dysfunction/death Abbreviations 8-HOG 8-Hydroxydeoxyguanosine ABAD Ab-binding dehydrogenase Ab b-Amyloid ACD Autophagic cell death AChR Acetylcholine receptor AD Alzhe…”
BackgroundInfluentialTau pathophysiology in neurodegeneration: a tangled issue
Spires-Jones, T. L., Stoothoff, W. H., de Calignon, A., Jones, P. B., & Hyman, B. T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.007 · Cited by 315 · cited 7×
“Recent evidence suggests a non-apoptotic caspaseassociated form of cell death occurring in tauopathy (Spires-Jones et al. 2009).”
BackgroundInfluentialAutophagy in neurodegenerative disease: friend, foe or turncoat?
Nixon, R. A. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.003 · Cited by 314 · cited 2×
“Emerging evidence supports the view that induction of autophagy is a neuroprotective process and that inadequate or defective autophagy, rather than excessive autophagy, compromises degradation of UPS substrates and, thus, promotes cell death (Korolchuk et al. 2009; Nixon 2006).”
BackgroundRole of complement in neurodegeneration and neuroinflammation
BONIFATI, D., & KISHORE, U. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.03.007 · Cited by 313 · cited 2×
“pro-inflammatory agent inducing the activation of glia and many of the inflammatory components (Bonifati and Kishore 2007; Farfara et al. 2008; Sondag et al. 2009).”
BackgroundAutophagy: Principles and significance in health and disease
Todde, V., Veenhuis, M., & van der Klei, I. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.016 · Cited by 313 · cited 3×
“Proteins that remain unfolded are degraded not only by the UPS, and the phagosome–lysosome system (Tai and Schuman 2008) or autophagy with three major pathways: chaperone-mediated autophagy (CMA), micro- and macroautophagy (Todde et al. 2009) (Fig.”
BackgroundOxidative Damage in Huntington's Disease Pathogenesis
Browne, S. E., & Beal, M. F. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 310 · cited 3×
“The crucial initiation mechanism induced by mutant huntingtin (mhtt) is still unclear, but a large body of evidence supports an early and critical involvement of defects in mitochondrial function and CNS energy metabolism in the disease trigger (Browne and Beal 2006).”
BackgroundMitochondrial complex I deficiency: from organelle dysfunction to clinical disease
Distelmaier, F., Koopman, W. J. H., van den Heuvel, L. P., Rodenburg, R. J., Mayatepek, E., Willems, P. H. G. M., & Smeitink, J. A. M. (2008) · Brain · doi:10.1093/brain/awp058 · Cited by 310 · cited 1×
“OXPHOS disorders ranging from Leigh disease to PD and AD are caused by defects of mitochondrial energy metabolism, related to complex deficiency (Distelmaier et al. 2009).”
BackgroundComplex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308 · cited 2×
“Both contribute to neuronal cell death via decreased protein pumping and reduced voltage differential across the inner mitochondrial membrane inducing not direct opening of the mitochondrial PTP, but rather leading to an increase of the ‘‘releasable’’ soluble pool of cytochrome c in the mitochondrial intermembrane spa…”
BackgroundOxidative and Inflammatory Pathways in Parkinson’s Disease
Miller, R. L., James-Kracke, M., Sun, G. Y., & Sun, A. Y. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9656-2 · Cited by 306 · cited 2×
“…PD, many biochemical changes indicate compromised antioxidant systems suggested to underlie cellular vulnerability to progressive OS which generates excessive ROS or free radicals in SN with subsequent cell damage (see Jellinger 2007a; Linert et al. 2006; Miller et al. 2009; Olivares et al. 2009).”
BackgroundFerrer, I., Gomez-Isla, T., Puig, B., Freixes, M., Ribe, E., Dalfo, E., & Avila, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772713 · Cited by 304 · cited 1×
“Tau phosphorylation is mediated by stress kinases (increased SAPK/JNK and p38) in dystrophic neurites of senile plaques (Ferrer et al. 2005).”
BackgroundProteomic and oxidative stress analysis in human brain samples of Huntington disease
Sorolla, M. A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.014 · Cited by 301 · cited 1×
“Proteomic and OS analyses in human brain samples of HD indicate that OS and damage to specific macromolecules would participate in disease progression (Sorolla et al. 2008).”
BackgroundCalcium ions in neuronal degeneration
Wojda, U., Salinska, E., & Kuznicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 301 · cited 3×
“ER stress is caused by disturbances in its structure and function with accumulation of misfolded proteins and alterations in calcium homeostasis (Wojda et al. 2008).”
BackgroundOxidative and nitrosative stress in Parkinson's disease
Tsang, A. H. K., & Chung, K. K. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.006 · Cited by 300 · cited 2×
“the core of LBs indicating their in damaging structural proteins (Tsang and Chung 2008).”
BackgroundMutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons
Chang, D. T. W., Rintoul, G. L., Pandipati, S., & Reynolds, I. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.007 · Cited by 299 · cited 2×
“Mitochondria in mutant cells are particularly vulnerable to stresses induced by Ca2? and reactive oxygen species (Lim et al. 2008), and mhtt aggregates impair mitochondrial movement and intracellular vesicular trafficking in cortical neurons (Chang et al. 2006; Caviston and Holzbaur 2009).”
BackgroundK-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 299 · cited 2×
“2006), as are decreases in ATP production and ATPsensitive potassium channels (Liss et al. 2005; Moore et al. 2005).”
Background
Research works printed but not linked: 2
- Mattson P, Bazan NG (2006) Apoptosis and necrosis. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 603–615
- Morfini GA, Stenoien DL, Brady ST (2006) Axonal transport. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 485–501
Cited by
KEGG: integrating viruses and cellular organisms
Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M., & Tanabe, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa970 · Cited by 3,436
Microalgae for High-Value Products Towards Human Health and Nutrition
Barkia, I., Saari, N., & Manning, S. R. (2019) · Marine Drugs · doi:10.3390/md17050304 · Cited by 719
“This is supported by the overproduction of ROS in early-stage patients that results in cleaving and misfolding of the amyloid precursor protein to amyloid beta-peptide (Aβ), which induces mitochondrial dysfunction and facilitates the formation of amyloid plaques [230].”
BackgroundPhotoreceptor degeneration: genetic and mechanistic dissection of a complex trait
Wright, A. F., Chakarova, C. F., Abd El-Aziz, M. M., & Bhattacharya, S. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2717 · Cited by 631
“Integrating diverse cellular stresses Some themes, such as increased RONS and bioenergetic dysfunction, recur in the PR cell-death mechanisms discussed above, but how do the different mechanisms converge on a final common death pathway? Similar mechanistic themes have been identified for neurodegenerative disorders th…”
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“1 Algorithm for classification of neurodegenerative diseases with protein deposits (proteinopathies) (from [1]).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Jellinger, K. A.
- Corresponding author
- Jellinger, Kurt A.
- ORCID
- Jellinger, Kurt A.
- Venue
- Journal of Neural Transmission
- Published
- 2009-06-05
- Volume
- 116
- Issue
- 9
- Pages
- 1111-1162
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2091026347
- Cited by
- 274
- References
- 618
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 12 · 2023: 11 · 2022: 11 · 2021: 13 · 2020: 13 · 2019: 17 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 27 · 2012: 23
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurodegeneration, proteinopathies, protein misfolding, ubiquitin-proteasome system, autophagy, oxidative stress, mitochondrial dysfunction, Golgi apparatus, molecular chaperones, neurotrophins, neuroinflammation, programmed cell death, amyloid-beta, tau protein, alpha-synuclein, TDP-43, preclinical diagnosis, common pathogenic mechanisms, neurodegenerative disease classification
- MeSH terms
- Free Radicals, Humans, Models, Biological, Mutation, Nerve Tissue Proteins, Protein Folding, Oxidative Stress, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.